|
| |
 |
|
Cobra
Biomanufacturing Launches New Website
|
Keele, UK, 17 April 2008: Cobra Biomanufacturing Plc (AIM: CBF), the
international manufacturer of biopharmaceuticals, today announces the launch of
its new website at www.cobrabio.com .
The launch of the new website follows the recent appointment of Simon Saxby as
COO, and represents a significant step forward in the growth and development of
the company. In particular, the website has been redesigned to reflect the
continued expansion of Cobra’s commercial supply capabilities. Visitors to the
website, which showcases a new corporate identity, will also benefit from
improved navigation, additional information on quality and services and a news
alert facility.
COO, Simon Saxby said: “The new identity and website are part of a very positive
step forward for the Company. We are developing our services and capabilities to
match the growth and development of current and new customers as they complete
clinical trial phases and begin to develop commercial supply processes.”
Cobra has extensive experience in the manufacture of proteins, DNA and viruses
for therapeutic use in pre-clinical through to Phase III clinical trials, with
additional commercial supply capabilities at its site in Oxford. The Company has
also added the BIOSTAT® CultiBag RM cell cultivation system to its offering,
providing a single-use option for both process development and cGMP
manufacturing.
- Ends -
For further information, please contact:
Cobra Biomanufacturing Plc
Tel: +44 (0) 1782 714 181
Simon Saxby, Chief Operating Officer
Buchanan Communications
Tel: +44 (0) 207 466 5000
Tim Anderson/Rebecca Skye Dietrich
College Hill Life Sciences
Tel: +44 (0) 1260 296 500
Kathryn Robertson
Seymour Pierce (NOMAD & Broker)
Tel: +44 (0) 20 107 8000
Stuart Lane
Notes to Editors:
About Cobra Biomanufacturing Plc: Cobra Biomanufacturing Plc is a leading
international manufacturer of biopharmaceuticals to the lifescience industry.
Founded in 1992, Cobra provides innovative manufacturing solutions to the
biopharmaceutical industry covering DNA, virus, cellular therapeutics and
recombinant protein products.
Cobra has developed a range of unique, patented technologies, which underpin a
successful revenue generating contract manufacturing business.
www.cobrabio.com
| |
|
